Phase I trial of daily pomalidomide in patients with advanced solid tumors

被引：3
|
作者：
Cooney, M. M.
Bokar, J. A.
Dreicer, R.
Krishnamurthi, S. S.
Savvides, P.
Nock, C. J.
Rodal, M. B.
Henderson, L.
Dowlati, A.
机构：
[1] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA
[2] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[3] Univ Hosp Case Med Ctr, Cleveland, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e13077
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13077
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I trial of pomalidomide given for patients with advanced solid tumors
    Matthew M. Cooney
    Charles Nock
    Joseph Bokar
    Smitha Krishnamurthi
    Joseph Gibbons
    Mary Beth Rodal
    Anne Ness
    Scot C. Remick
    Robert Dreicer
    Afshin Dowlati
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 755 - 761
  • [2] Phase I trial of pomalidomide given for patients with advanced solid tumors
    Cooney, Matthew M.
    Nock, Charles
    Bokar, Joseph
    Krishnamurthi, Smitha
    Gibbons, Joseph
    Rodal, Mary Beth
    Ness, Anne
    Remick, Scot C.
    Dreicer, Robert
    Dowlati, Afshin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (05) : 755 - 761
  • [3] Phase I trial of daily imatinib mesylate and weekly paclitaxel in patients with advanced refractory solid tumors
    Bahrani, A
    Hwang, J
    Malik, S
    Marshall, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 216S - 216S
  • [4] A phase I trial of bexarotene and docetaxel in patients with advanced solid tumors
    Malik, S. M.
    Marshall, J. L.
    Ramzi, P.
    Deeken, J. F.
    Pishvaian, M. J.
    Hwang, J. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] A phase I trial of perillyl alcohol in patients with advanced solid tumors
    Azzoli, CG
    Miller, VA
    Ng, KK
    Krug, LM
    Spriggs, DR
    Tong, WP
    Riedel, ER
    Kris, MG
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 51 (06) : 493 - 498
  • [6] Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors
    Joanna M. Brell
    Smitha S. Krishnamurthi
    Linda Rath
    Joseph A. Bokar
    Panayiotis Savvides
    Joseph Gibbons
    Matthew M. Cooney
    Neal J. Meropol
    Percy Ivy
    Afshin Dowlati
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 547 - 553
  • [7] A phase I trial of perillyl alcohol in patients with advanced solid tumors
    Christopher G. Azzoli
    Vincent A. Miller
    Kenneth K. Ng
    Lee M. Krug
    David R. Spriggs
    William P. Tong
    Elyn R. Riedel
    Mark G. Kris
    Cancer Chemotherapy and Pharmacology, 2003, 51 : 493 - 498
  • [8] Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors
    Brell, Joanna M.
    Krishnamurthi, Smitha S.
    Rath, Linda
    Bokar, Joseph A.
    Savvides, Panayiotis
    Gibbons, Joseph
    Cooney, Matthew M.
    Meropol, Neal J.
    Ivy, Percy
    Dowlati, Afshin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (04) : 547 - 553
  • [9] Phase I trial of figitumumab and pegvisomant in patients with advanced solid tumors
    Haluska, P. H.
    Dudek, A. Z.
    Bono, P.
    Sleight, B.
    Joensuu, H.
    Juergens, H.
    Pollak, M.
    ANNALS OF ONCOLOGY, 2011, 22 : 39 - 39
  • [10] Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors
    Sanborn, Sharon L.
    Gibbons, Joseph
    Krishnamurthi, Smitha
    Brell, Joanna M.
    Dowlati, Afshin
    Bokar, Joseph A.
    Nock, Charles
    Horvath, Nancy
    Bako, Jacob
    Remick, Scot C.
    Cooney, Matthew M.
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (05) : 453 - 460
12345